UB Paderborn / Katalog / Suche / in CDI

First oral warfarin alternative approved in the US

Nature reviews. Drug discovery, 2010-12, Vol.9 (12), p.903-906

Hughes, Bethan

2010

Volltextzugriff (PDF)

Exaggerations and Caveats in Press Releases and Health-Related Science News

PloS one, 2016-12, Vol.11 (12), p.e0168217-e0168217

2016

Volltextzugriff (PDF)

Antibody–drug conjugates for cancer: poised to deliver?

Nature reviews. Drug discovery, 2010-09, Vol.9 (9), p.665-667

Hughes, Bethan

2010

Volltextzugriff (PDF)

Metformin-associated lactic acidosis reported to the United Kingdom National Poisons Information Service (NPIS) between 2010 and 2019: a ten-year retrospective analysis

Clinical toxicology (Philadelphia, Pa.), 2023-06, Vol.61 (6), p.445-452

2023

Volltextzugriff (PDF)

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

Frontiers in oncology, 2023-12, Vol.13, p.1284089-1284089

2023

Volltextzugriff (PDF)

Hydrogenase activity in the foodborne pathogen Campylobacter jejuni depends upon a novel ABC-type nickel transporter (NikZYXWV) and is SlyD-independent

Microbiology (Society for General Microbiology), 2012-06, Vol.158 (Pt 6), p.1645

2012

Volltextzugriff (PDF)

2009 FDA drug approvals

Nature reviews. Drug discovery, 2010-02, Vol.9 (2), p.89-92

Hughes, Bethan

2010

Volltextzugriff (PDF)

2007 FDA drug approvals: a year of flux

Nature reviews. Drug discovery, 2008-02, Vol.7 (2), p.107-109

Hughes, Bethan

2008

Volltextzugriff (PDF)

2008 FDA drug approvals

Nature reviews. Drug discovery, 2009-02, Vol.8 (2), p.93-96

Hughes, Bethan

2009

Volltextzugriff (PDF)

Illuminating weight loss

Nature reviews. Drug discovery, 2008-03, Vol.7 (3), p.203-203

Hughes, Bethan

2008

Volltextzugriff (PDF)

Evolving R&D for emerging markets

Nature reviews. Drug discovery, 2010-06, Vol.9 (6), p.417-420

2010

Volltextzugriff (PDF)

Novel consortium to address shortfall in innovative medicines for psychiatric disorders

Nature reviews. Drug discovery, 2009-07, Vol.8 (7), p.523-524

Hughes, Bethan

2009

Volltextzugriff (PDF)

China spurs pharma innovation

Nature reviews. Drug discovery, 2010-08, Vol.9 (8), p.581-582

Hughes, Bethan

2010

Volltextzugriff (PDF)

Pharma pursues novel models for academic collaboration

Nature reviews. Drug discovery, 2008-08, Vol.7 (8), p.631-632

Hughes, Bethan

2008

Volltextzugriff (PDF)

The association between exaggeration in health related science news and academic press releases: retrospective observational study

BMJ (Online), 2014-12, Vol.349 (7987), p.g7015

International edition, 2014

Volltextzugriff (PDF)

Industry concern over EU hepatotoxicity guidance

Nature reviews. Drug discovery, 2008-09, Vol.7 (9), p.719-719

Hughes, Bethan

2008

Volltextzugriff (PDF)

Priority voucher flops

Nature biotechnology, 2011-11, Vol.29 (11), p.958-958

Hughes, Bethan

2011

Volltextzugriff (PDF)

A Wellcome experiment in seeding drug discovery

Nature reviews. Drug discovery, 2010-03, Vol.9 (3), p.178-180, Article 178

Hughes, Bethan

2010

Volltextzugriff (PDF)

FDA inspections online

Nature biotechnology, 2011-08, Vol.29 (8), p.676-676

Hughes, Bethan

2011

Volltextzugriff (PDF)

Developing tools for stratified medicine

Nature reviews. Drug discovery, 2009-12, Vol.8 (12), p.919-920

Hughes, Bethan

2009

Volltextzugriff (PDF)

Gearing up for follow-on biologics

Nature reviews. Drug discovery, 2009-03, Vol.8 (3), p.181-181

Hughes, Bethan

2009

Volltextzugriff (PDF)

Large drugs outdo small

Nature biotechnology, 2011-04, Vol.29 (4), p.296-296

Hughes, Bethan

2011

Volltextzugriff (PDF)

Novel agents combined get own guidance

Nature biotechnology, 2011-03, Vol.29 (3), p.174-174

Hughes, Bethan

2011

Volltextzugriff (PDF)

First oral warfarin alternative approved in the US: for more than 50 years, warfarin has been the standard of care for long-term anticoagulation therapy in the United States, but now the FDA has approved the first oral anticoagulant that could replace it

Nature reviews. Drug discovery, 2010-12, Vol.9 (12)

Hughes, Bethan

2010

Volltextzugriff (PDF)

An audience with ... Luciano Rossetti

Nature reviews. Drug discovery, 2010-10, Vol.9 (10), p.758

Hughes, Bethan

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

First oral warfarin alternative approved in the US

Exaggerations and Caveats in Press Releases and Health-Related Science News

Antibody–drug conjugates for cancer: poised to deliver?

Metformin-associated lactic acidosis reported to the United Kingdom National Poisons Information Service (NPIS) between 2010 and 2019: a ten-year retrospective analysis

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

Hydrogenase activity in the foodborne pathogen Campylobacter jejuni depends upon a novel ABC-type nickel transporter (NikZYXWV) and is SlyD-independent

2009 FDA drug approvals

2007 FDA drug approvals: a year of flux

2008 FDA drug approvals

Illuminating weight loss

Evolving R&D for emerging markets

Novel consortium to address shortfall in innovative medicines for psychiatric disorders

China spurs pharma innovation

Pharma pursues novel models for academic collaboration

The association between exaggeration in health related science news and academic press releases: retrospective observational study

Industry concern over EU hepatotoxicity guidance

Priority voucher flops

A Wellcome experiment in seeding drug discovery

FDA inspections online

Developing tools for stratified medicine

Gearing up for follow-on biologics

Large drugs outdo small

Novel agents combined get own guidance

First oral warfarin alternative approved in the US: for more than 50 years, warfarin has been the standard of care for long-term anticoagulation therapy in the United States, but now the FDA has approved the first oral anticoagulant that could replace it

An audience with ... Luciano Rossetti

Suchergebnisse filtern